YM150
150-CL-029
Phase 2 small_molecule completed
Quick answer
YM150 for Thromboembolism is a Phase 2 program (small_molecule) at Astellas Pharma Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma Inc
- Indication
- Thromboembolism
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed